Skip to navigation Skip to content



About this Medication
  • Brand Name: Kesimpta® (kes·imp·ta)
  • Chemical Name: Ofatumumab (oh-fah-TOO-moo-mab)
  • Usage in MS: Disease-Modifying Agent
  • Generic Available: No

This medication is taken by injection.


Kesimpta® is a monoclonal antibody that binds to a docking site (CD20) on some immune B cells and depletes them. B cells are among immune cells that have been implicated in causing nervous system damage in MS. Kesimpta is approved by the FDA for the treatment of relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease (RRMS) and active secondary progressive disease, in adults.

Read the Society's news bulletin on the FDA approval of ofatumumab here.

Click here to see the prescribing information for healthcare professionals.

Click here to see the medication guide for patients.

1-855-KESIMPTA (1-855-537-4678)

Financial Assistance Program

Alongside™ KESIMPTA®


© 2024 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.